The semisynthetic vitamin E derivative alpha-tocopheryloxyacetic acid (α-TEA) can stimulate autophagy to strengthen MHCI cross-presentation of tumor antigens to antigen-special CD8+ T cells, which is viewed as an adjuvant strategy to improve immunotherapy by reinforcing anti-tumor immune responses [62, 63]. The gene discussed is CD8A; the disease is neoplasm.